United States
US 12,697,330 B2
Therapeutic methods using vadadustat
US 12,697,330 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Akebia Therapeutics, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Akebia Therapeutics, Inc.
- Inventors
- Steven BURKE; Ajit CHAVAN; Zeeshan KHAWAJA
- Publication date
- 2026-08-04
- Filing date
- 2023-06-29
- Document type
- B2 Granted patent
- Also written as
- US 12,697,330 B2 · US12697330 · 12697330
Abstract
This invention provides methods for the treatment of anemia in patients with chronic kidney disease (CKD) using vadadustat (Compound 1). Methods described herein provide alternative dosing regimens for patients having anemia. In addition, methods herein are suitable for patients converting from a previous anemia treatment including erythropoietin stimulating agent (ESA), patients who are on dialysis (e.g., peritoneal dialysis or hemodialysis), or CKD patients having certain hemoglobin (Hb) levels.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free